“
The validation from Dassault Systèmes selecting Smartweave as one of just three startups from over 1,000 global applicants spoke volumes.
Round open now on Wefunder · $218,856 raised · 33 investors · First goal hit
The Surgical Scaffold Industry Has a Design Problem.
We're Solving It.
Smartweave uses AI and patient-specific biology to personalize connective tissue repair - the first platform of its kind. Backed by Dassault Systèmes, $18M+ in institutional support, and a team from Stanford and Cedars-Sinai.
SMARTWEAVE INVESTMENT ROUND
Join Early Investors Building The Future Of Personalized Regenerative Medicine.
Start with as little as $100 or discuss a larger investment opportunity directly.
$218,856+
Raised
33+
Investors
$35M
Valuation Cap
$100
Minimum
THE PROBLEM WE'RE SOLVING
Every Connective Tissue Scaffold in Use Today Was Designed Without the Patient's Biology.
The result is documented failure at scale.
45%
Complication rate from current pelvic repair devices
10–30%
ACL reconstruction re-injury rate within 12 months
10–50%+
Rotator cuff repair failure with generic materials
No current device on the market incorporates the patient's biological data at the design stage. Smartweave does.
THE SMARTS™ SYSTEM
Patient Biology Drives the Design.
Our AI platform reads each patient's inflammatory risk, matches a personalized formulation, and simulates the surgical outcome before the scaffold is manufactured.
01
Patient Biology Input
02
AI Risk Classification
03
Formulation Match
04
Digital Twin Simulation
05
Personalized Scaffold
Pelvic Repair
HeraWeave™
Pelvic floor repair for women affected by urogynecological conditions.
Orthopedic
OrthoWeave™
Bioprinted ACL and tendon scaffolds matched to native tissue biomechanics.
Cardiac
CardioWeave™
Custom cardiac valve replacements matched to individual heart anatomy.
Dental
DentaWeave™
Light-curable periodontal gel tuned to each patient's inflammation profile.
SMARTWEAVE INVESTMENT ROUND
Join Early Investors Building The Future Of Personalized Regenerative Medicine.
Start with as little as $100 or discuss a larger investment opportunity directly.
INSTITUTIONAL VALIDATION
$18M+ Secured Before We Ever Asked the Public.
◎
1 of 3
Selected by Dassault Systèmes from 1,000+ global ventures
⌂
1 of 15
Selected by Swiss EPFL Tech4Eva from 300+ ventures
$
$6.4M
Grants and institutional support secured pre-raise
↔
$12M+
Secured by clinical collaborators for pre-IND R&D
▣
$1.6M
IP revenue generated over the past 2 years
✦
150+ Years
Team expertise across Stanford, Cedars-Sinai, Medtronic, J&J
Dassault Systèmes selected Smartweave as one of only 3 ventures from 1,000+ global companies.
$218,856 raised · 33 investors · First goal hit ✓ · Round still open
INVESTOR VALIDATION
Backed by investors who believe personalized medicine is the next major shift in surgical care.
Raj’s Investor Network33 investors requested more insight after seeing Smartweave’s institutional validation.
Investor Interest